K Hao

Summary

Country: China

Publications

  1. ncbi Genome-wide selection of tag SNPs using multiple-marker correlation
    K Hao
    Algorithm and Data Analysis, Affymetrix, Inc, 3420 Central Expressway, Santa Clara, California, USA
    Bioinformatics 23:3178-84. 2007
  2. ncbi Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies
    Ke Hao
    Genetics Department, Rosetta Inpharmatics, a Wholly Owned Subsidiary of Merck and Co Inc, Seattle, Washington, USA
    BMC Genet 10:27. 2009
  3. ncbi Clinicopathologic and gene expression parameters predict liver cancer prognosis
    Ke Hao
    Merck Research Laboratories, Boston, MA, USA
    BMC Cancer 11:481. 2011
  4. ncbi LdCompare: rapid computation of single- and multiple-marker r2 and genetic coverage
    K Hao
    Algorithm and Data Analysis, Affymetrix Inc 3420 Central Expressway, Santa Clara, California, USA
    Bioinformatics 23:252-4. 2007
  5. ncbi SNPkit: an efficient approach to systematic evaluation of candidate single nucleotide polymorphisms in public databases
    K Hao
    Harvard School of Public Health, Boston, MA, USA
    Biotechniques 33:822, 824-6, 828 passim. 2002

Detail Information

Publications5

  1. ncbi Genome-wide selection of tag SNPs using multiple-marker correlation
    K Hao
    Algorithm and Data Analysis, Affymetrix, Inc, 3420 Central Expressway, Santa Clara, California, USA
    Bioinformatics 23:3178-84. 2007
    ..Thus, tag SNP selection methods that incorporate multiple-marker LD are expected to have advantages in terms of genetic coverage and statistical power...
  2. ncbi Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies
    Ke Hao
    Genetics Department, Rosetta Inpharmatics, a Wholly Owned Subsidiary of Merck and Co Inc, Seattle, Washington, USA
    BMC Genet 10:27. 2009
    ..Genome-wide imputation of untyped markers allows us to address these issues in a direct fashion...
  3. ncbi Clinicopathologic and gene expression parameters predict liver cancer prognosis
    Ke Hao
    Merck Research Laboratories, Boston, MA, USA
    BMC Cancer 11:481. 2011
    ..However, there has been little systematic effort to compare the performance of these two types of predictors or combine them in a comprehensive model...
  4. ncbi LdCompare: rapid computation of single- and multiple-marker r2 and genetic coverage
    K Hao
    Algorithm and Data Analysis, Affymetrix Inc 3420 Central Expressway, Santa Clara, California, USA
    Bioinformatics 23:252-4. 2007
    ..Source code, documentation, testing datasets and precompiled executables are available for download at: http://www.affymetrix.com/support/developer/tools/devnettools.affx..
  5. ncbi SNPkit: an efficient approach to systematic evaluation of candidate single nucleotide polymorphisms in public databases
    K Hao
    Harvard School of Public Health, Boston, MA, USA
    Biotechniques 33:822, 824-6, 828 passim. 2002
    ..Overall, by using SNPkit, we have been able to validate and genotype accurately a large fraction of publicly available SNPs without sophisticated instrumentation...